314 related articles for article (PubMed ID: 23934116)
1. Th1 not Th17 cells drive spontaneous MS-like disease despite a functional regulatory T cell response.
Lowther DE; Chong DL; Ascough S; Ettorre A; Ingram RJ; Boyton RJ; Altmann DM
Acta Neuropathol; 2013 Oct; 126(4):501-15. PubMed ID: 23934116
[TBL] [Abstract][Full Text] [Related]
2. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
3. Serotonin decreases the production of Th1/Th17 cytokines and elevates the frequency of regulatory CD4
Sacramento PM; Monteiro C; Dias ASO; Kasahara TM; Ferreira TB; Hygino J; Wing AC; Andrade RM; Rueda F; Sales MC; Vasconcelos CC; Bento CAM
Eur J Immunol; 2018 Aug; 48(8):1376-1388. PubMed ID: 29719048
[TBL] [Abstract][Full Text] [Related]
4. CCR5 ameliorates Japanese encephalitis via dictating the equilibrium of regulatory CD4(+)Foxp3(+) T and IL-17(+)CD4(+) Th17 cells.
Kim JH; Patil AM; Choi JY; Kim SB; Uyangaa E; Hossain FM; Park SY; Lee JH; Eo SK
J Neuroinflammation; 2016 Jul; 13(1):223. PubMed ID: 27439902
[TBL] [Abstract][Full Text] [Related]
5. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
[TBL] [Abstract][Full Text] [Related]
6. Nr4a1 plays a crucial modulatory role in Th1/Th17 cell responses and CNS autoimmunity.
Wang LM; Zhang Y; Li X; Zhang ML; Zhu L; Zhang GX; Xu YM
Brain Behav Immun; 2018 Feb; 68():44-55. PubMed ID: 28962999
[TBL] [Abstract][Full Text] [Related]
7. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
8. CD4 T cell-intrinsic IL-2 signaling differentially affects Th1 and Th17 development.
Fujimura K; Oyamada A; Iwamoto Y; Yoshikai Y; Yamada H
J Leukoc Biol; 2013 Aug; 94(2):271-9. PubMed ID: 23715742
[TBL] [Abstract][Full Text] [Related]
9. T cell-specific BLIMP-1 deficiency exacerbates experimental autoimmune encephalomyelitis in nonobese diabetic mice by increasing Th1 and Th17 cells.
Lin MH; Yeh LT; Chen SJ; Chiou HY; Chu CC; Yen LB; Lin KI; Chang DM; Sytwu HK
Clin Immunol; 2014 Apr; 151(2):101-13. PubMed ID: 24568746
[TBL] [Abstract][Full Text] [Related]
10. Thymol as a reciprocal regulator of T cell differentiation: Promotion of regulatory T cells and suppression of Th1/Th17 cells.
Namdari H; Izad M; Rezaei F; Amirghofran Z
Int Immunopharmacol; 2019 Feb; 67():417-426. PubMed ID: 30586665
[TBL] [Abstract][Full Text] [Related]
11. Lineage-Specific Metabolic Properties and Vulnerabilities of T Cells in the Demyelinating Central Nervous System.
Seki SM; Stevenson M; Rosen AM; Arandjelovic S; Gemta L; Bullock TNJ; Gaultier A
J Immunol; 2017 Jun; 198(12):4607-4617. PubMed ID: 28507026
[TBL] [Abstract][Full Text] [Related]
12. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
Bar-Or A; Fawaz L; Fan B; Darlington PJ; Rieger A; Ghorayeb C; Calabresi PA; Waubant E; Hauser SL; Zhang J; Smith CH
Ann Neurol; 2010 Apr; 67(4):452-61. PubMed ID: 20437580
[TBL] [Abstract][Full Text] [Related]
13. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.
Batoulis H; Addicks K; Kuerten S
Ann Anat; 2010 Aug; 192(4):179-93. PubMed ID: 20692821
[TBL] [Abstract][Full Text] [Related]
14. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
[TBL] [Abstract][Full Text] [Related]
15. High incidence of spontaneous disease in an HLA-DR15 and TCR transgenic multiple sclerosis model.
Ellmerich S; Mycko M; Takacs K; Waldner H; Wahid FN; Boyton RJ; King RH; Smith PA; Amor S; Herlihy AH; Hewitt RE; Jutton M; Price DA; Hafler DA; Kuchroo VK; Altmann DM
J Immunol; 2005 Feb; 174(4):1938-46. PubMed ID: 15699121
[TBL] [Abstract][Full Text] [Related]
16. Th17 cells in central nervous system autoimmunity.
Sie C; Korn T; Mitsdoerffer M
Exp Neurol; 2014 Dec; 262 Pt A():18-27. PubMed ID: 24681001
[TBL] [Abstract][Full Text] [Related]
17. Differential requirements for Th1 and Th17 responses to a systemic self-antigen.
Katzman SD; Gallo E; Hoyer KK; Abbas AK
J Immunol; 2011 Apr; 186(8):4668-73. PubMed ID: 21402892
[TBL] [Abstract][Full Text] [Related]
18. Green tea EGCG, T cells, and T cell-mediated autoimmune diseases.
Wu D; Wang J; Pae M; Meydani SN
Mol Aspects Med; 2012 Feb; 33(1):107-18. PubMed ID: 22020144
[TBL] [Abstract][Full Text] [Related]
19. Dysfunction of IL-10-producing type 1 regulatory T cells and CD4(+)CD25(+) regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys.
Ma A; Xiong Z; Hu Y; Qi S; Song L; Dun H; Zhang L; Lou D; Yang P; Zhao Z; Wang X; Zhang D; Daloze P; Chen H
Int Immunopharmacol; 2009 May; 9(5):599-608. PubMed ID: 19539557
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T cells suppress development of colitis, blocking differentiation of T-helper 17 into alternative T-helper 1 cells.
Sujino T; Kanai T; Ono Y; Mikami Y; Hayashi A; Doi T; Matsuoka K; Hisamatsu T; Takaishi H; Ogata H; Yoshimura A; Littman DR; Hibi T
Gastroenterology; 2011 Sep; 141(3):1014-23. PubMed ID: 21699791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
